National Cancer Center Hospital; Gastrointestinal Oncology

Tokyo 104-0045

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer

Studies at this site

• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer — Completed
• A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer — Stopped early